Table 2

Data used to calculate the probability of CP
MgSO4 No MgSO4 Source
Marrett 352 336 8
CP 22 30
Mittendorf 30 29 9
CP 3 0
Crowther 533 513 10
CP 36 42
Mild (GMFCS level I/II) 21 21 a
Moderate (GMFCS level III) 12 15 a
Severe (GMFCS level IV/V) 3 6 a
Rouse 1030 1107 11
CP 41 74
Mild (GMFCS level I/II) 28 49 b
Moderate (GMFCS level III) 8 9 b
Severe (GMFCS level IV/V) 5 16 b

Total number of patients assessed and number with each outcome in each of the four trials. Note that only data on patients to whom magnesium sulphate was administered for the specific purpose of fetal neuroprotection was included in the present analyses.

aAssumed with reference to the study protocol and detailed descriptions of characteristics for each GMFCS level for children under the age of four.

bD. Rouse, MD, written communication, March 2011.

Bickford et al.

Bickford et al. BMC Health Services Research 2013 13:527   doi:10.1186/1472-6963-13-527

Open Data